肾肿块活检中同轴技术与序贯(非同轴)技术的比较:诊断效能、并发症发生率、种植风险与临床结局评估
回顾性研究2004至2020年间1174个小型肾肿块活检,比较同轴技术与序贯技术的诊断率、并发症、种植、pT3a升级和复发。同轴技术诊断率与序贯技术无显著差异(87% vs 88%,p=0.62),并发症率同轴组更高(4% vs 2%,p=0.04),但校正影像方式后差异不显著(p=0.35)。种植罕见,仅2例乳头状肾细胞癌各用一种技术发生,两种技术在种植、升级和复发上无差异。
要点
- 同轴与序贯技术诊断率无显著差异:87%(600/692)vs 88%(425/482),p=0.62。
- 同轴技术并发症率更高(4% vs 2%,p=0.04),但校正影像方式后不显著(p=0.35)。
- 肿瘤种植罕见,仅2例乳头状肾细胞癌,两种技术各1例,随访未复发。
核心结论
- 同轴针肾肿块活检与更高的诊断率、更低的肿瘤种植、更低的pT3a升级或更低的复发无关;种植罕见,仅见于2例乳头状肾细胞癌,两种活检技术均可发生;由于缺乏一种技术优于另一种的证据,可根据可用性和偏好选择活检技术。
研究设计与样本
- 回顾性研究,纳入2004年至2020年间有活检技术信息的1174个小型肾肿块活检,同轴技术占59%,序贯技术占41%。
关键影像表现/征象
- 2例肿瘤种植表现为切除标本中肾肿块旁肾周脂肪内微小碎片,均为乳头状肾细胞癌,随访未复发。
- 414个切除的小型肾肿块中5%(20/414)在肾切除后升级为pT3a。
诊断标准与关键数值
- 诊断率:同轴技术87%(600/692)vs 序贯技术88%(425/482),p=0.62。
- 并发症率:同轴技术4%(31/692)vs 序贯技术2%(10/482),p=0.04;校正影像方式后p=0.35。
- pT3a升级率:同轴技术3%(8/231)vs 序贯技术7%(12/183),p=0.14。
- 切缘阳性与疾病复发在两组间无差异(p=0.82,0.39)。
临床应用与阅片要点
- 肾肿块活检中同轴与序贯技术诊断效能相当,可根据可用性和操作者偏好选择。
- 同轴技术并发症率数值上更高,但校正影像方式后差异不显著。
- 肿瘤种植罕见,仅见于乳头状肾细胞癌,两种技术均可发生。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Renal mass biopsy (RMB) enables histology-driven management. Guidelines strongly recommend RMB using a coaxial needle to minimize tumor seeding, albeit with a low level of supporting evidence.
OBJECTIVES: To evaluate if RMB in small renal masses (SRMs) with the coaxial technique was associated with lower seeding, less upstaging to pT3a, and less cancer-recurrence, compared to RMB without the coaxial technique (sequential technique).
MATERIALS AND METHODS: Retrospective study of RMB performed between 2004 and 2020, where biopsy-technique information was available. 1174 SRMs were biopsied (coaxial-59%; sequential-41%). Diagnostic yield, complication, procedure-time, seeding, upstaging to pT3a after nephrectomy, and cancer-recurrence were compared.
RESULTS: Diagnostic yield did not differ significantly between coaxial and sequential techniques 87% (600/692) vs. 88% (425/482); p = 0.62. Complication rates were higher for the coaxial technique (31/692 (4%) vs. 10/482 (2%); p = 0.04). This difference was not significant after adjusting for imaging modality used (p = 0.35). There were 2 subjects with tumor seeding (tiny fragments in the perinephric fat beside the renal mass in the resected surgical specimen), one patient with each technique. Both were papillary RCCs and did not recur on follow-up. Of the 414 resected SRMs, 5% (20/414) were upstaged to pT3a after nephrectomy, and did not differ between coaxial and sequential groups (3%,8/231 vs. 7%,12/183; p = 0.14). There was no difference in the positive margins or disease recurrence (p = 0.82, 0.39).
CONCLUSIONS: RMB with a coaxial needle was not associated with higher yield, lower tumor seeding, lower upstaging, or lower recurrence. Tumor seeding is rare, observed in only two patients with papillary RCC, occurring with either biopsy technique. Due to a lack of evidence for the superiority of one technique, availability and preference may guide the choice of biopsy technique.
KEY POINTS: QuestionRisk of seeding after renal mass biopsies (RMB) remains a concern, and the overall risk of seeding and whether the coaxial technique mitigates that risk is unknown. Findings Seeding was exceedingly rare after RMB. There was no difference in seeding, upgrading, or recurrence between sequential and coaxial techniques. Clinical relevanceIt has been suggested that tumor seeding after RMB may be prevented using a coaxial needle. Our results have demonstrated that RMB with or without a coaxial needle is equally safe, and these were not associated with an increased risk of complications, needle tract seeding, or disease recurrence.
引用
- Garcia MP, Finelli A, Bhayana R, et al. Comparison of coaxial technique with sequential (non-coaxial) technique for renal mass biopsy: evaluation of diagnostic efficacy, complication rates, seeding risk, and clinical outcomes. Eur Radiol. 2025. PMID: 40815307. doi:10.1007/s00330-025-11894-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。